Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML

Описание к видео Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML

Jorge Cortes, MD, Director of the Georgia Cancer Center, talks about the approval of ponatinib for adults with chronic-phase chronic myeloid leukemia (CML).

Комментарии

Информация по комментариям в разработке